ArticleExperimental and therapeutic medicine2020

miR-454 promotes survival and induces oxaliplatin resistance in gastric carcinoma cells by targeting CYLD.

Chaoqun Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.